ReNeuron Group plc
RNUGF · OTC
9/30/2023 | 3/31/2023 | 9/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $4,218 | $4,171 | $17,381 | $16,501 |
| - Cash | $5,075 | $6,153 | $9,464 | $9,548 |
| + Debt | $345 | $421 | $496 | $562 |
| Enterprise Value | -$512 | -$1,561 | $8,413 | $7,515 |
| Revenue | $157 | $92 | $438 | $345 |
| % Growth | 70.7% | -79% | 27% | – |
| Gross Profit | -$2,020 | -$1,385 | $306 | $197 |
| % Margin | -1,286.6% | -1,505.4% | 69.9% | 57.1% |
| EBITDA | -$3,220 | -$2,754 | -$2,005 | -$2,431 |
| % Margin | -2,051% | -2,993.5% | -457.8% | -704.6% |
| Net Income | -$2,841 | -$2,232 | -$3,176 | -$4,455 |
| % Margin | -1,809.6% | -2,426.1% | -725.1% | -1,291.3% |
| EPS Diluted | -0.05 | -0.039 | -0.056 | -0.078 |
| % Growth | -27.4% | 29.9% | 28.8% | – |
| Operating Cash Flow | -$2,101 | -$3,161 | -$4,291 | -$2,789 |
| Capital Expenditures | $0 | -$64 | -$156 | -$64 |
| Free Cash Flow | -$2,101 | -$3,225 | -$4,447 | -$2,853 |